Transaktionen anzeigen
Gesundheitswesen

The Canton of Solothurn had a valuation report prepared for its hospitals

The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.

As part of its audit work, the Solothurn Cantonal Audit Office, as external auditors, had a second opinion prepared, which answers various questions in connection with soH’s annual impairment test and other valuation questions.

The Oaklins team in Switzerland was able to draw on its longstanding experience and profound expertise in valuation topics for this challenging assignment. It conducted the relevant valuation analyses, interviewed management and external stakeholders and answered and documented the specific questions in a comprehensive report.

PARTEIEN
«We as well as management of Spitäler AG found the collaboration extremely pleasant and professional. The report is of great benefit to us. You responded perfectly to our needs and provided us with what we needed. My expectations have been more than fulfilled.»

Gabrielle Rudolf von Rohr

Head of the Cantonal Audit Office, Solothurn

Sprechen Sie mit dem Deal Team

Dr. Daniel Spring

Partner
Bern, Schweiz
Oaklins Switzerland

Dr. Roberto Tracia

Partner
Bern, Schweiz
Oaklins Switzerland

Daniel Eichenberger

Associate
Bern, Schweiz
Oaklins Switzerland

Transaktionen

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
Private Equity | Gesundheitswesen | TMT

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital

RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.

Mehr erfahren
Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.
Gesundheitswesen

Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.

Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.

Mehr erfahren
Pharma-Skan & Skan-Medic have been acquired by Brygge Partners
Gesundheitswesen

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

Mehr erfahren